检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]南通大学第三附属医院检验科,江苏无锡214041
出 处:《国际检验医学杂志》2014年第19期2593-2594,共2页International Journal of Laboratory Medicine
基 金:无锡市医院管理中心医学技术重大扶持项目(YGZF1101)
摘 要:目的探讨急性白血病患者外周血白细胞介素(IL)-2、干扰素-γ(IFN-γ)、IL-10水平及血清乳酸脱氢酶(LDH)活性的变化。方法将65例急性白血病患者分为未缓解组(35例)和缓解组(30例),另选取健康体检者50例为对照组。采用酶联免疫吸附试验(ELISA)检测外周血IL-2、IFN-γ和IL-10的水平,采用全自动生化分析仪检测血清中LDH的活性。结果未缓解组IL-2和IFN-γ水平均明显低于对照组和缓解组(P<0.05),而IL-10水平则明显高于对照组和缓解组(P<0.05);未缓解组血清中LDH活性明显高于对照组和缓解组,差异有统计学意义(P<0.05)。结论急性白血病患者外周血中IL-2、IFN-γ、IL-10水平及血清中LDH活性会发生明显变化,临床上可以通过检测IL-2、IFN-γ、IL-10水平及LDH活性对急性白血病患者进行早期诊断。Objective To study the levels of interleukin(IL)-2 ,interferon-γ(IFN-γ) and IL-10 in peripheral blood and the effec-tive concentration of lactate dehydrogenase(LDH) in serum of patients with acute leukemia .Methods 65 patients with acute leuke-mia were divided into non-remission group(n=35) and remission group(n=30) .50 healthy volunteers were used as control group . The levels of IL-2 ,IFN-γ ,IL-10 in peripheral blood were measured by enzyme linked immunosorbent assay(ELISA) .The effective concentration of LDH was measured by automatic biochemical analyzer .Results The levels of IL-2 ,IFN-γin non-remission group were significantly decreased compared with control group and remission group(P〈0 .05) ,but the level of IL-10 in non-remission group was significantly increased compared with control group and remission group(P〈0 .05) .The effective concentration of LDH in non-remission group was significantly higher than that in control group or remission group(P〈0 .05) .Conclusion The levels of IL-2 ,IFN-γand IL-10 in peripheral blood and the effective concentration of LDH in serum of patients with acute leukemia have changed .Clinical detection of IL-2 ,IFN-γ,IL-10 and LDH may contribute to the early diagnosis of patients with acute leukemia .
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.116.239.148